Applying interventions designed to reduce and manage the symptoms of substance use disorders.
Treatment
Can a "treatment specialist" also be seen as a "prevention specialist" and vice versa?
A contribution by Jeff Lee from the ISSUP INEP Plus facilitators training course.
VCU researchers are developing a long-acting medication for opioid addiction
Researchers at Virginia Commonwealth University (VCU) have developed a new version of a medication for opioid use disorder that could offer longer-lasting treatment. Current medications for opioid addiction often require daily doses, but...
Motivational Interviewing: A Pathway to Partnership in Care
Motivational Interviewing (MI) has long been a personal favourite amongst intervention modalities. Much of the work my teams and I have done in the Addiction Psychiatry Division at the University of Cape Town has been anchored in MI’s core...
Overcoming barriers to traditional care delivery and pharmacy challenges: a qualitative study of buprenorphine, telehealth, and a digital therapeutic for opioid use disorder
Background The opioid epidemic in the U.S. contributes to increased morbidity and mortality from drug overdoses, but barriers to traditional opioid use disorder (OUD) treatment limit access to care. During the COVID-19 pandemic, Public...
Alcohol use disorder among people diagnosed with tuberculosis in a large urban case-finding project in central Uganda
Background Heavy alcohol consumption increases the risk of developing tuberculosis (TB), delays diagnosis, and affects treatment adherence. This study aimed to examine the prevalence of alcohol use disorder (AUD) among individuals with TB...
Validation of the alcohol use disorders identification test in a Danish hospital setting
Background Early identification of alcohol problems is important for timely intervention. The Alcohol Use Disorders Identification Test (AUDIT) and its shorter version, AUDIT-C, are widely used screening tools. This study tested the...
Anti-Stigma Network: Developing inclusion - substance use related stigma across general practise
What positive steps can we make to ensure that stigmatisation within a GP setting is reduced for people who use drugs and alcohol? A person-centred approach, appropriate language and addressing implicit bias could be key. Hear from three healthcare providers across the UK and Ireland who share their experiences and tips for best practice.
Time: 12:30PM - 2PM UK Time
Nonmedical Benzodiazepines in Canada
The Canadian Community Epidemiology Network on Drug Use (CCENDU), co-ordinated by the Canadian Centre on Substance Use and Addiction (CCSA), publishes this newsletter regularly to inform people living in Canada about emerging substance use...
UTC - 4 Based Basic Counselling Skills programme
UTC - 4 Based Basic Counselling Skills Programme Basic counseling skills and drug counseling are a valuable tool for the development of a very important function in Sri Lankan society. The importance of a scientific and evidence-based...
2025 NIDA International Forum: Research Poster Abstract Submission and Travel Award Requests
Join the National Institute on Drug Abuse (NIDA) International Program for the 2025 NIDA International Forum, which will be held June 13–14, 2025, at the Sheraton New Orleans Hotel in New Orleans, Louisiana, USA. The Forum research...